# First Molecular Identification and Clinical Presentation of Crenosomosis in a Dog from Slovakia

**Authors:** Michaela Kaduková, Martin Kožár, Andrea Schreiberová, Barbora Šišková, Gabriela Štrkolcová

PMC · DOI: 10.1007/s11686-024-00861-8 · 2024-06-29

## TL;DR

This paper reports the first confirmed case of Crenosoma vulpis lungworm infection in a dog from Slovakia, diagnosed using molecular methods.

## Contribution

The study provides the first molecular confirmation of Crenosoma vulpis in a dog in Slovakia.

## Key findings

- Crenosoma vulpis was identified in a dog with persistent cough and breathing difficulties.
- Molecular analysis confirmed the presence of C. vulpis using mitochondrial and nuclear gene markers.
- Fenbendazole treatment was effective in managing the infection.

## Abstract

Crenosoma vulpis (Dujardin,1845) is a lungworm which has spread worldwide in canines and is associated with upper respiratory infections. In a majority of cases, the infections are accompanied with chronic cough. Diagnosis of lungworms is often underdiagnosed and can be misinterpreted as other respiratory diseases.

The Small Animal Clinic of the University Veterinary Hospital admitted an 11-month-old dog presented with persistent cough associated with difficulty in breathing and even asphyxia. Based on clinical symptoms, the patient underwent radiological and bronchoscopic examination. Bronchoscopy revealed the presence of lungworms obturating the branches of the tracheobronchial tree. Larvae were collected by bronchoscopic lavage and subjected to parasitological and molecular examination.

Microscopic detection and morphological identification of the worms removed during the bronchoscopy confirmed the presence of female adult worms. The subsequent molecular characterisation of the mitochondrial (cytochrome c oxidase subunit I gene (cox1) and 12S ribosomal DNA (rDNA)), nuclear (18S rDNA) genes, as well as the analysis of the second internal transcribed spacer (ITS-2) region of the ribosomal DNA, confirmed the Crenosoma vulpis species. Faecal samples were processed using the Baermann method, which confirmed the presence of the larval stage 1 of C. vulpis. The therapy with fenbendazole at a dose of 50 mg/kg of live weight once daily for the period of 7 days was initiated for the patient.

This paper presents the first molecularly confirmed clinical case of a Crenosoma vulpis infection in an 11-month-old female dog of the Miniature Schnauzer breed in Slovakia.

## Linked entities

- **Genes:** ITS2 (isoleucine-trna synthetase) [NCBI Gene 7445294]
- **Chemicals:** fenbendazole (PubChem CID 3334)
- **Diseases:** upper respiratory infections (MONDO:0024355)
- **Species:** Crenosoma vulpis (taxon 321390)

## Full-text entities

- **Genes:** COX1 (cytochrome c oxidase subunit I) [NCBI Gene 4512] {aka COI, MTCO1}
- **Diseases:** upper respiratory infections (MESH:D012141), respiratory diseases (MESH:D012140), asphyxia (MESH:D001237), chronic cough (MESH:D003371), lungworm (MESH:C536369), Crenosoma vulpis infection (MESH:D007239)
- **Chemicals:** fenbendazole (MESH:D005273)
- **Species:** Homo sapiens (human, species) [taxon 9606], Crenosoma vulpis (species) [taxon 321390], lungworms [taxon 6310], Canis lupus familiaris (dog, subspecies) [taxon 9615]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11379797/full.md

---
Source: https://tomesphere.com/paper/PMC11379797